USB450870I5 - - Google Patents

Info

Publication number
USB450870I5
USB450870I5 US45087074A USB450870I5 US B450870 I5 USB450870 I5 US B450870I5 US 45087074 A US45087074 A US 45087074A US B450870 I5 USB450870 I5 US B450870I5
Authority
US
United States
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to US05/450,870 priority Critical patent/US3998951A/en
Publication of USB450870I5 publication Critical patent/USB450870I5/en
Application granted granted Critical
Publication of US3998951A publication Critical patent/US3998951A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/93—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
US05/450,870 1974-03-13 1974-03-13 Substituted 2-arylquinazolines as fungicides Expired - Lifetime US3998951A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US05/450,870 US3998951A (en) 1974-03-13 1974-03-13 Substituted 2-arylquinazolines as fungicides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/450,870 US3998951A (en) 1974-03-13 1974-03-13 Substituted 2-arylquinazolines as fungicides

Publications (2)

Publication Number Publication Date
USB450870I5 true USB450870I5 (Direct) 1976-03-16
US3998951A US3998951A (en) 1976-12-21

Family

ID=23789842

Family Applications (1)

Application Number Title Priority Date Filing Date
US05/450,870 Expired - Lifetime US3998951A (en) 1974-03-13 1974-03-13 Substituted 2-arylquinazolines as fungicides

Country Status (1)

Country Link
US (1) US3998951A (Direct)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0537600A1 (en) * 1991-10-07 1993-04-21 Dowelanco An improved process for the preparation of 4-haloquinazolines

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182879A (en) * 1975-09-24 1980-01-08 Hoffmann-La Roche Inc. N-[3-methyl-4-(2-methyl-4-oxo-3,4-dihydro-quinazolin-3-yl)phenyl]succinamic acid
US4159330A (en) * 1976-11-02 1979-06-26 Carlo Erba S.P.A. 2-Disubstituted phenyl-3,4-dihydro-4-oxo-quinazoline derivatives and process for their preparation
FI70036C (fi) * 1980-01-31 1986-09-12 Ciba Geigy Ag Kromogena kinazolinfoereningar
US4625027A (en) * 1982-10-25 1986-11-25 Ciba-Geigy Corporation Bisquinazolines useful in color former systems
US4668966A (en) * 1984-04-18 1987-05-26 Ciba-Geigy Corporation Aliphatic bridged chromogenic bisquinazolines substituted with phenylamine or phenyl-containing heterobicyclic radicals
US4639454A (en) * 1985-01-17 1987-01-27 E. I. Du Pont De Nemours And Company Phenylquinazolinecarboxylic acids and derivatives as cancer chemotherapeutic agents
IL89029A (en) * 1988-01-29 1993-01-31 Lilly Co Eli Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them
RU2340611C2 (ru) * 2000-09-15 2008-12-10 Вертекс Фармасьютикалз Инкорпорейтед Производные пиразола, используемые в качестве ингибиторов протеинкиназы
ZA200301701B (en) * 2000-09-15 2004-03-01 Vertex Pharma Pyrazole compounds useful as protein kinase inhibitors.
US7473691B2 (en) * 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6660731B2 (en) * 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
WO2002022604A1 (en) * 2000-09-15 2002-03-21 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
SI1318997T1 (sl) * 2000-09-15 2006-12-31 Vertex Pharma Pirazolne spojine, uporabne kot inhibitorji protein-kinaze
CA2432131C (en) * 2000-12-21 2008-07-08 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
JP4656838B2 (ja) * 2002-02-06 2011-03-23 バーテックス ファーマシューティカルズ インコーポレイテッド Ｇｓｋ−３の阻害剤として有用なヘテロアリール化合物
US20040009981A1 (en) * 2002-03-15 2004-01-15 David Bebbington Compositions useful as inhibitors of protein kinases
MY141867A (en) 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
NZ538426A (en) 2002-08-02 2007-05-31 Vertex Pharma Pyrazole compositions useful as inhibitors of glycogen synthase kinase-3 (GSK-3)
US7601718B2 (en) * 2003-02-06 2009-10-13 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
AU2004297235A1 (en) * 2003-12-04 2005-06-23 Vertex Pharmaceuticals Incorporated Quinoxalines useful as inhibitors of protein kinases
EP1917259B1 (en) * 2005-08-18 2012-01-25 Vertex Pharmaceuticals Incorporated Pyrazine kinase inhibitors
JP5249770B2 (ja) 2005-11-03 2013-07-31 バーテックス ファーマシューティカルズ インコーポレイテッド キナーゼインヒビターとして有用なアミノピリジン
JP2010509231A (ja) * 2006-11-02 2010-03-25 バーテックス ファーマシューティカルズ インコーポレイテッド プロテインキナーゼの阻害剤として有用なアミノピリジンおよびアミノピリミジン
NZ577768A (en) * 2006-12-19 2012-01-12 Vertex Pharma Aminopyrimidines useful as inhibitors of protein kinases
AU2008226461A1 (en) * 2007-03-09 2008-09-18 Vertex Pharmaceuticals Incorporated Aminopyridines useful as inhibitors of protein kinases
ES2374335T3 (es) * 2007-03-09 2012-02-15 Vertex Pharmaceuticals Incorporated Aminopirimidinas útiles como inhibidores de proteína quinasas.
MX2009009590A (es) * 2007-03-09 2009-11-10 Vertex Pharma Aminopirimidinas utiles como inhibidores de proteinas cinasas.
CN101679386A (zh) 2007-04-13 2010-03-24 沃泰克斯药物股份有限公司 可用作激酶抑制剂的氨基嘧啶类化合物
MX2009011812A (es) * 2007-05-02 2010-01-14 Vertex Pharma Aminopirimidinas utiles como inhibidores de cinasa.
MX2009011811A (es) * 2007-05-02 2010-01-14 Vertex Pharma Aminopirimidinas utiles como inhibidores de cinasa.
MX2009011810A (es) * 2007-05-02 2010-01-14 Vertex Pharma Tiazoles y pirazoles utiles como inhibidores de cinasa.
CN101687852A (zh) * 2007-05-24 2010-03-31 沃泰克斯药物股份有限公司 可用作激酶抑制剂的噻唑类和吡唑类化合物
CA2694499A1 (en) * 2007-07-31 2009-02-05 Vertex Pharmaceuticals Incorporated Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
JP2012501971A (ja) * 2008-09-03 2012-01-26 バーテックス ファーマシューティカルズ インコーポレイテッド 共結晶および共結晶を含む薬学的処方物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1880447A (en) * 1932-10-04 Max haedtmann
US3755582A (en) * 1971-03-04 1973-08-28 Du Pont Quinazolinone fungicides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1880447A (en) * 1932-10-04 Max haedtmann
US3755582A (en) * 1971-03-04 1973-08-28 Du Pont Quinazolinone fungicides

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Chemical Abstracts, vol. 55 (1961), p. 1009h. *
Chemical Abstracts, vol. 76 (1972), p. 149497u. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0537600A1 (en) * 1991-10-07 1993-04-21 Dowelanco An improved process for the preparation of 4-haloquinazolines

Also Published As

Publication number Publication date
US3998951A (en) 1976-12-21

Similar Documents

Publication Publication Date Title
FR2293928B1 (Direct)
USB450870I5 (Direct)
FI750111A7 (Direct)
FI49951B (Direct)
FI752391A7 (Direct)
DK133827C (Direct)
FI751329A7 (Direct)
FR2256854B1 (Direct)
CS170053B1 (Direct)
CS174568B1 (Direct)
CH581722A5 (Direct)
BG20424A1 (Direct)
BG19628A1 (Direct)
BG19673A1 (Direct)
BG19694A1 (Direct)
BG19701A1 (Direct)
DD117386A2 (Direct)
DD112836A1 (Direct)
DD109537A1 (Direct)
BG19714A1 (Direct)
CH586405A5 (Direct)
BG20230A1 (Direct)
BG20660A1 (Direct)
BG20467A1 (Direct)
BG20211A1 (Direct)